Xiang‐An Zhao
- Hepatology top 10%
- Hepatitis C virus research 7
- Liver Disease and Transplantation 3
- Liver physiology and pathology 3
-
- Immunotherapy and Immune Responses 2
-
- Liver Disease Diagnosis and Treatment 8
- Hepatitis B Virus Studies 8
-
- Drug-Induced Hepatotoxicity and Protection 2
-
- Adenosine and Purinergic Signaling 1
- Cited by
- HepatologyImmunologyEpidemiology
- Journals
- Oncotarget (1 paper)Biomedicine & Pharmacotherapy (1 paper)Clinical & Experimental Immunology (2 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Xiang‐An Zhao
17 papers receiving 321 citations
Peers
Comparison fields: 5 of 61
- Hepatology 114
- Immunology 111
- Epidemiology 152
- Molecular Medicine 13
- Pharmacology 19
Countries citing papers authored by Xiang‐An Zhao
This map shows the geographic impact of Xiang‐An Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang‐An Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang‐An Zhao more than expected).
Fields of papers citing papers by Xiang‐An Zhao
This network shows the impact of papers produced by Xiang‐An Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang‐An Zhao. The network helps show where Xiang‐An Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiang‐An Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2021 | 7 | |
| 3 | 2021 | 12 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 17 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 7 | |
| 8 | 2018 | 38 | |
| 9 | 2018 | 14 | |
| 10 | 2018 | 19 | |
| 11 | 2018 | 6 | |
| 12 | Characteristics of peripheral and intrahepatic regulatory B cells in HBV-related liver cirrhosis. | 2018 | 4 |
| 13 | 2018 | 32 | |
| 14 | 2017 | 19 | |
| 15 | Inhibitory effect of silymarin on CCl4-induced liver fibrosis by reducing Ly6Chi monocytes infiltration. | 2017 | 13 |
| 16 | 2014 | 100 | |
| 17 | 2007 | 22 |
About Xiang‐An Zhao
Xiang‐An Zhao is a scholar working on Hepatology, Epidemiology and Internal Medicine, having authored 17 papers that have together received 322 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (8 papers), Hepatitis C virus research (7 papers), Liver Disease and Transplantation (3 papers), Liver physiology and pathology (3 papers), Immunotherapy and Immune Responses (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Adenosine and Purinergic Signaling (1 paper). The work is most often cited by research in Hepatology (114 citations), Immunology (111 citations) and Epidemiology (152 citations). Xiang‐An Zhao has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Chao Wu, Rui Huang, Yuxin Chen, Juan Xia, Yujie Zhou, Yucheng Zhong, Xiaobo Mao, Qingwei Ji, Qiutang Zeng and Bangwei Wu. Their work appears in journals such as Oncotarget, Biomedicine & Pharmacotherapy and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.